ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
News from Davos 2020: Some positive signs, but overall a fragile antibiotic market at a tipping point
De-risking vaccine development: Insights spanning decades of experience
Developing antibiotics for children: There are no easy answers
FDA workshop: Insights on inhaled antifungals and antibacterials
Developing systemic & inhaled antibiotics for lung infections
What does an antibiotic cost to develop? What is it worth? How to afford it?
Draft EMA antibacterial guidance: Analysis
How hard (and how) to Pull? Net value of Pull via a Transferrable Exclusivity Extension (TEE)
The hunt for oral antibiotics: Beyond Lipinski’s Rule of Five
Push! Pull! Push! Pull! / Highlights from Davos 2018
Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR
NIAID workshop: What is a robust PK-PD package?
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet